Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.v68.630207593
   PubMed Web of Science ®Google Scholar
• Christiansen MN, Chik J, Lee L, Anugraham M, Abrahams JL, Packer NH. Cell surface protein glycosylation in cancer. Proteomics. 2014;14(4–5):525–546. doi:10.1002/pmic.v14.4-524339177
   PubMed Web of Science ®Google Scholar
• Tian E, Ten Hagen KG. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J. 2009;26(3):325–334. doi:10.1007/s10719-008-9162-418695988
   PubMed Web of Science ®Google Scholar
• Kudelka MR, Antonopoulos A, Wang Y, et al. Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells. Nat Methods. 2016;13(1):81–86. doi:10.1038/nmeth.367526619014
   PubMed Web of Science ®Google Scholar
• Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 2006;7(6):599–604. doi:10.1038/sj.embor.740070516741504
   PubMed Web of Science ®Google Scholar
• Burchell JM, Beatson R, Graham R, Taylor-Papadimitriou J, Tajadura-Ortega V. O-linked mucin-type glycosylation in breast cancer. Biochem Soc Trans. 2018;46(4):779–788. doi:10.1042/BST2017048329903935
   PubMedGoogle Scholar
• Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1999;1473(1):67–95. doi:10.1016/S0304-4165(99)00170-110580130
   PubMed Web of Science ®Google Scholar
• Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540–555. doi:10.1038/nrc398226289314
   PubMed Web of Science ®Google Scholar
• Xia L, McEver RP. Targeted disruption of the gene encoding core 1 beta1-3-galactosyltransferase (T-synthase) causes embryonic lethality and defective angiogenesis in mice. Methods Enzymol. 2006;416:314–331.17113876
   PubMedGoogle Scholar
• Ju T, Xia B, Aryal RP, et al. A novel fluorescent assay for T-synthase activity. Glycobiology. 2011;21(3):352–362. doi:10.1093/glycob/cwq16820959392
   PubMed Web of Science ®Google Scholar
• Wang Y, Ju T, Ding X, et al. Cosmc is an essential chaperone for correct protein O-glycosylation. Proc Natl Acad Sci U S A. 2010;107(20):9228–9233. doi:10.1073/pnas.091400410720439703
   PubMed Web of Science ®Google Scholar
• Ju T, Lanneau GS, Gautam T, et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 2008;68(6):1636–1646. doi:10.1158/0008-5472.CAN-07-234518339842
   PubMed Web of Science ®Google Scholar
• Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A. 2002;99(26):16613–16618. doi:10.1073/pnas.26243819912464682
   PubMed Web of Science ®Google Scholar
• Ju T, Otto VI, Cummings RD. The Tn antigen-structural simplicity and biological complexity. Angew Chem Int Ed Engl. 2011;50(8):1770–1791. doi:10.1002/anie.v50.821259410
   PubMed Web of Science ®Google Scholar
• Ju T, Wang Y, Aryal RP, et al. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers. Proteomics Clin Appl. 2013;7(9–10):618–631. doi:10.1002/prca.20130002423857728
   PubMed Web of Science ®Google Scholar
• Konska G, Guerry M, Caldefie-Chezet F, De Latour M, Guillot J. Study of the expression of Tn antigen in different types of human breast cancer cells using VVA-B4 lectin. Oncol Rep. 2006;15(2):305–310. doi:10.3892/or.15.2.30516391846
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu Z, Xu F, et al. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. J Cell Mol Med. 2018;22(10):4875–4885. doi:10.1111/jcmm.1375229999571
   PubMed Web of Science ®Google Scholar
• Hofmann BT, Schluter L, Lange P, et al. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Mol Cancer. 2015;14:109. doi:10.1186/s12943-015-0386-126021314
   PubMed Web of Science ®Google Scholar
• Chugh S, Barkeer S, Rachagani S, et al. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice. Gastroenterology. 2018;155(5):1608–1624. doi:10.1053/j.gastro.2018.08.00730086262
   PubMed Web of Science ®Google Scholar
• Hua D, Shen L, Xu L, et al. Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer. Int J Mol Med. 2012;30(6):1267–1274. doi:10.3892/ijmm.2012.113022992780
   PubMed Web of Science ®Google Scholar
• Song K, Herzog BH, Fu J, et al. Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice. J Biol Chem. 2015;290(33):20159–20166. doi:10.1074/jbc.M115.65448326124270
   PubMed Web of Science ®Google Scholar
• Lin MC, Chien PH, Wu HY, et al. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer. Oncogene. 2018;37(43):5780–5793. doi:10.1038/s41388-018-0375-029930379
   PubMed Web of Science ®Google Scholar
• Wu YM, Liu CH, Huang MJ, et al. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Cancer Res. 2013;73(17):5580–5590. doi:10.1158/0008-5472.CAN-13-086923832667
   PubMed Web of Science ®Google Scholar
• Avichezer D, Springer GF, Schechter B, Arnon R. Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model. Int J Cancer. 1997;72(1):119–127. doi:10.1002/(ISSN)1097-02159212232
   PubMed Web of Science ®Google Scholar
• Ju T, Aryal RP, Stowell CJ, Cummings RD. Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc. J Cell Biol. 2008;182(3):531–542. doi:10.1083/jcb.20071115118695044
   PubMed Web of Science ®Google Scholar
• Aryal RP, Ju T, Cummings RD. The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase. J Biol Chem. 2010;285(4):2456–2462. doi:10.1074/jbc.M109.06516919923218
   PubMed Web of Science ®Google Scholar
• Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11(1):64. doi:10.1186/s13045-018-0605-529747682
   PubMed Web of Science ®Google Scholar
• Senbanjo LT, Chellaiah MA. CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells. Front Cell Dev Biol. 2017;5:18. doi:10.3389/fcell.2017.0001828326306
   PubMed Web of Science ®Google Scholar
• Ouhtit A, Rizeq B, Saleh HA, Rahman MM, Zayed H. Novel CD44-downstream signaling pathways mediating breast tumor invasion. Int J Biol Sci. 2018;14(13):1782–1790. doi:10.7150/ijbs.2358630443182
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600–604. doi:10.3109/10799893.2015.103041226096166
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Marx K, Reichl U, Wuhrer M, Rapp E. Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins. Mol Cell Proteomics. 2016;15(2):624–641. doi:10.1074/mcp.M115.05354626598643
   PubMed Web of Science ®Google Scholar
• Li S, Liu B, Zeng R, Cai Y, Li Y. Predicting O-glycosylation sites in mammalian proteins by using SVMs. Comput Biol Chem. 2006;30(3):203–208. doi:10.1016/j.compbiolchem.2006.02.00216731044
   PubMed Web of Science ®Google Scholar
• Deng B, Tarhan YE, Ueda K, et al. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells. Neoplasia. 2018;20(10):1038–1044. doi:10.1016/j.neo.2018.08.00630208353
   PubMed Web of Science ®Google Scholar
• Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P. Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res. 2010;12(3):204. doi:10.1186/bcr257720550729
   PubMed Web of Science ®Google Scholar
• Bard F, Chia J. Cracking the Glycome Encoder: signaling, Trafficking, and Glycosylation. Trends Cell Biol. 2016;26(5):379–388. doi:10.1016/j.tcb.2015.12.00426832820
   PubMed Web of Science ®Google Scholar
• Ju T, Aryal RP, Kudelka MR, Wang Y, Cummings RD. The Cosmc connection to the Tn antigen in cancer. Cancer Biomark. 2014;14(1):63–81. doi:10.3233/CBM-13037524643043
   PubMed Web of Science ®Google Scholar
• Mi R, Song L, Wang Y, et al. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen. J Biol Chem. 2012;287(49):41523–41533. doi:10.1074/jbc.M112.37198923035125
   PubMed Web of Science ®Google Scholar
• Radhakrishnan P, Dabelsteen S, Madsen FB, et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc Natl Acad Sci U S A. 2014;111(39):E4066–E4075. doi:10.1073/pnas.140661911125118277
   PubMed Web of Science ®Google Scholar
• Huang J, Che MI, Lin NY, et al. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK. Mol Carcinog. 2014;53(Suppl 1):E62–E71. doi:10.1002/mc.2201123390052
   PubMedGoogle Scholar
• Chou CH, Huang MJ, Chen CH, et al. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway. Oncotarget. 2015;6(8):6123–6135. doi:10.18632/oncotarget.304525762620
   PubMedGoogle Scholar
• Liu Z, Liu J, Dong X, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23(3):2083–2092. doi:10.1111/jcmm.2019.23.issue-330637914
   PubMed Web of Science ®Google Scholar
• Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174–183. doi:10.1016/S1470-2045(09)70262-120152769
   PubMed Web of Science ®Google Scholar
• Campos D, Freitas D, Gomes J, et al. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. Mol Cell Proteomics. 2015;14(6):1616–1629. doi:10.1074/mcp.M114.04686225813380
   PubMed Web of Science ®Google Scholar
• Mallard BW, Tiralongo J. Cancer stem cell marker glycosylation: nature, function and significance. Glycoconj J. 2017;34(4):441–452. doi:10.1007/s10719-017-9780-928624993
   PubMed Web of Science ®Google Scholar
• Menon MM, Thakur R, Simha MR, Kurkure AP, Kenkare UW, Doctor VM. Expression of cell surface glycoprotein CD44 and integrins in breast cancers among Indian women. Tumori J. 1998;84(5):589–594. doi:10.1177/030089169808400515
   PubMed Web of Science ®Google Scholar
• Wang JS, Wang HJ, Qian HL. Biological effects of radiation on cancer cells. Mil Med Res. 2018;5(1):20. doi:10.1186/s40779-018-0167-429958545
   PubMedGoogle Scholar
• Bourguignon LY. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6(3):287–297. doi:10.1023/A:101137152399411547898
   PubMed Web of Science ®Google Scholar
• Reddy P, Caras I, Krieger M. Effects of O-linked glycosylation on the cell surface expression and stability of decay-accelerating factor, a glycophospholipid-anchored membrane protein. J Biol Chem. 1989;264(29):17329–17336.2477368
   PubMed Web of Science ®Google Scholar